Pt/TiO2 brain biocompatible nanoparticles: GBM treatment using the C6 model in Wistar rats

Acta Biomaterialia

Volumn 4, Issue 6, 2008, Pages 2037-2044

  Lopez T ^a,b   Recillas, S ^a,b   Guevara, P ^b   Sotelo, J ^b   Alvarez, M ^a,b   Odriozola, J A ^c  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c CSIC   (Spain)

Author keywords

Cancer; Nanoparticles; Nanotherapy; Platinum; TiO2

Indexed keywords

BIOCOMPATIBILITY; DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; PLATINUM COMPOUNDS; SOL-GEL PROCESS; SOL-GELS; SYNTHESIS (CHEMICAL); TUMORS;

ANIMAL MODEL; BIOCOMPATIBLE NANOPARTICLES; GLIOMA CELLS; INORGANIC OXIDES; NANOTHERAPY; OXIDE NANOPARTICLES; PT/TIO 2; SYNTHESISED; THERAPEUTIC EFFECTS; WISTAR RAT;

TITANIUM DIOXIDE;

NANOPARTICLE; PLATINUM COMPLEX; TETRAAMINEPLATINUM CHLORIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; PLATINUM; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CHEMICAL BINDING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; GLIOBLASTOMA; INFRARED SPECTROSCOPY; MALE; NANOPHARMACEUTICS; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RAT; TUMOR REGRESSION; TUMOR VOLUME; WISTAR RAT; ANIMAL; BRAIN TUMOR; CHEMISTRY; MICELLE; RAMAN SPECTROMETRY; TUMOR CELL LINE;

ANIMALIA; RATTUS NORVEGICUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG CARRIERS; GLIOBLASTOMA; MALE; MICELLES; NANOPARTICLES; PHASE TRANSITION; PLATINUM; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; TITANIUM;

EID: 53649091140     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.05.027     Document Type: Article

References (30)

1. Sahoo S.K., Parveen S., and Panda J.J. The present and future of nanotechnology in human health care. Nanomedicine NBM 3 (2007) 20-31
2. Kim K.Y. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine 3 (2007) 103-110
3. Liu H., and Webster T.J. Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials 28 (2007) 354-369
4. Black P.M. Brain tumor. Part 2. N Engl J Med 324 (1991) 1555-1564
5. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Del Rev 54 (2002) 631-651
6. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41 (2001) 189-207
7. Lukyanov A.N., Gao Z., Mazzola L., and Torchilin V.P. Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 19 (2002) 1424-1429
8. Yokoyama M., Okano T., Sakurai Y., Suwa S., and Kataoka K. Introduction of cisplatin into polymeric micelles. J Control Release 39 (1996) 351-356
9. Bogdanov Jr. A., Wright S.C., Marccos E.M., Bogdanova A., Martin C., Petherick P., et al. A long-circulating copolymer in "passive targeting" to solid tumors. J Drug Target 4 (1997) 321-330
10. Radozs M, Shen Y, Tang H. Nanoparticles for cytoplasmatic drug delivery to cancer cells. Patent WO 2007/001356 A2; January 2007.
11. LaVan D.A., McGuire T., and Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 21 (2003) 1184-1191
12. Díaz A., López T., Manjarrez J., Basaldella E., Martínez-Blanes J.M., and Odriozola J.A. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica. Acta Biomater 2 (2006) 173-179
13. López T., Ortiz E., Quintana P., and González R.D. A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain. Coll Surf A 300 (2007) 3-10
14. Arrieta O., Guevara P., Escobar E., García-Navarrete R., Pineda B., and Sotelo J. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Brit J Cancer 92 (2005) 1247-1252
15. Peterson D., Sheridan P., and Brown W. Animal models for brain tumors: historical perspectives and futures directions. J Neurosurg 80 (1994) 865-876
16. Payen E., Grimblot J., Lavalley J.-C., Daturi M., and Mauge F. Vibrational spectroscopy in the study of oxide and sulfide catalysts (excluding zeolites). In: Chalmers J.M., and Griffiths R. (Eds). Handbook of Vibrational Spectroscopy (2002), John Wiley & Sons Ltd, London 3005-3041
17. Glazunov V.P., and Odinokov S.E. Infrared spectra of pyridinium salts in solution - I. The region of middle frequencies. Spectrochim. Acta 38A (1982) 399-408
18. Travert A., Vimont A., Sahibed-Dine A., Daturi M., and Lavalley J.-C. Use of pyridine CH(D) vibrations for the study of Lewis acidity of metal oxides. Appl. Catal. A 307 (2006) 98-107
19. Tarasiewicz J., Jakubas R., and Baran J. Infrared studies of phase transitions in ferroelectric (C5H5NH)5Bi2Br11. Vib Spectrosc 40 (2006) 55-65
20. Cheremisina I.M., Sobolev E.V., and Mal'chikov G.D. Stretching vibrations of metal-ligand bonds in some platinum(II) and platinum(IV) complexes. J Struct Chem 15 (1974) 378-383
21. Drozdova L., Novakova J., Schulz-Ekloff G., and Jaeger N.I. Ship-in-bottle synthesis of palladium carbonyl complexes in NaY and NaX zeolites via the direct carbonylation of Pd(NH3)42+. Micropor Mesopor Mater 28 (1999) 395-403
22. Hadjiivanov K.I., and Vayssilov G.N. Characterization of oxide surfaces and zeolites by carbon monoxide as an IR probe molecule. Adv Catal 47 (2002) 307-511
23. Hadjiivanov K.I., and Klissurski D.G. Surface chemistry of titania (anatase) and titania-supported catalysts. Chem Soc Rev 25 (1996) 61-69
24. 2 anatase. Langmuir 13 (1997) 3374-3381
25. Koranyi T.I., Mihaly J., Pfeifer E., Nemeth C., Yuzhakova T., and Mink J. Infrared emission and theoretical study of carbon monoxide adsorbed on alumina-supported Rh, Ir, and Pt catalysts. J Phys Chem A 110 (2006) 1817-1823
26. Bastl Z., Beneke M., Brabec L., Jaeger N.I., Hulstede P., Novakova J., et al. NaX-encaged Pt carbonyls: reversible substitution of CO ligands by oxygen and ammonia. Evidence for a conservation of the polynuclear Pt skeleton. Phys Chem Chem Phys 2 (2000) 3099-3104
27. Kubelkova L., Drozdova L., Brabec L., Novakova J., Kotrla J., Hulstede P., et al. Anionic Pt carbonyl complexes in faujasites: matrix effect. J Phys Chem 100 (1996) 15517-15524
28. Deubel D.V. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study. J Am Chem Soc 128 (2006) 1654-1663
29. Eastman A. Cell cycle checkpoints and their impact on anticancer therapeutics strategies. J Cell Biochem 91 (2003) 223-231
30. Wang G., Reed E., and Li Q.Q. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer. Oncol Rep 12 (2004) 955-965